timothy sykes logo

Penny Stocks News

The Best Penny Stock To Short Sell & Research On A5 LABORATORIES INC (AFLB) & AEterna Zentaris Inc. (AEZS)

Timothy SykesAvatar
Written by Timothy Sykes
Updated 2/22/2021 5 min read

Glad to be short this pump RMCP overnight:

And here’s some solid research:

A5 LABORATORIES INC (AFLB) (New)
– Pump, now really gets accelerated
– $930,000 paid promoted stock
– look here for promotional article(a specially bottom part)  https://www2.smallcapfortunes.com/a5/index.html
*CFM has received and managed a total production budget of $900,000 for this advertising effort and will retain any amounts over and above the cost of production, copywriting services, mailing and other distribution expenses, as a fee for its services. Untapped Wealth is paid $3,000 as an editorial fee from CFM and also expects to receive new subscriber revenue as a result of this advertising effort.
– SEC 23-Aug-2010 10-Q: https://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=7428009-5103-62817&type=sect&dcn=0001062993-10-002772
*A5 Laboratories Inc., (the “Company”) was incorporated in the State of Nevada on June 21, 2006. The Company was originally incorporated as El Palenque Nercery, Inc. and changed its name to El Palenque Vivero, Inc. on June 30, 2006. On March 23, 2010, it further changed its name to A5 Laboratories Inc. It is based in Lachine Quebec, Canada. The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America, and the Company’s fiscal year end is September 30.
*For the three months ended June 30, 2010 we incurred a net loss of $69,156
*From June 21, 2006 to June 30, 2010 our net loss was $144,712 and our expenses were $146,627.
*During the nine month periods ended June 30, 2010 we received $162,500 in cash from financing activities compared to $Nil for the same period in 2009. From our inception on June 21, 2006 to June 30, 2010 we received $264,500 through financing activities; entirely from the sale of our common shares.
*We anticipate that we will meet our ongoing cash requirements by selling our equity securities or through existing shareholder loans
*Issued and outstanding shares: 45,750,000 common shares
*Deficit accumulated $(144,712)
*On March 9, 2010, the Board authorized a 10 for 1 forward split of its common stock effective April 8, 2010.
*During the period ended June 30, 2010, the Company issued 250,000 common shares at $0.65 per share for total cash proceeds of $162,500 being $250 for par value shares and $162,250 for additional paid in capital.
*Of these shares, 19,000,000 were issued to directors and officers of the Company and 26,750,000 were issued to independent investors.
– SEC 7-Jul-2010 8-K: https://biz.yahoo.com/e/100707/aflb.ob8-k.html
*On June 18, 2010 we entered into a CRO asset acquisition agreement and an Interferon asset acquisition agreement (collectively, the “Agreements”) with Vida Nutra Pharma Inc., a company incorporated under the laws of Canada (“Vida”) and on July 5, 2010 we closed the transactions contemplated by the Agreements. Pursuant to the terms of the Agreements we issued options to acquire an aggregate of 1,000,000 shares of our common stock at $0.001 per share for a period of 60 months to Vida in exchange for the assets contemplated by the Agreements.

AEterna Zentaris Inc. (AEZS) (New)
– bounced from its bottom $1 (where it based for several days after reporting weak earnings on August 12 https://finance.yahoo.com/news/Aeterna-Zentaris-Reports-prnews-3428216655.html?x=0&.v=1) to $1.17 (in 2 days) when MicroStockProfit.com covered this company
– September 1, 2010, 6:50 am AEterna Zentaris Inc. is Today’s Focus Stock on MicroStockProfit.com
*Let’s look Disclaimer part in MicroStockProfit.com site:
*This website is a service of BlueWave Advisors, LLC, a financial public relations firm that has been compensated by the companies profiled.
**not good
– The report also puts a link to https://www.stockhideout.com
*As typical we have to look out the Disclaimer link of the site:
*The website is a service of BlueWave Advisors, LLC and StockHideout, LLC. BlueWave Advisors, LLC owns seventy five percent of the outstanding membership interests of StockHideout, LLC. Stock_Analyzer owns twenty five percent of the outstanding membership interests of StockHideout, LLC. StockHideout, LLC is a financial public relations firm that has been compensated by the companies profiled. Additionally, Stock_Analyzer is compensated up to but no more than six thousand dollars monthly each for stock discussion related services on various stocks from Oceanic Consulting, LLC on a need basis. Stock_Analyzer may have time periods of no weekly or monthly work for Oceanic Consulting, LLC.
**now we are sure that both StockHideout & MicroStockProfit are controlled by BlueWave Advisors which receives compensation from profiled companies.
– Shares Short (as of Aug 13, 2010):    3.78M  8.30% of Float:    78.89M
– probably they are trying to squeeze shorts


How much has this post helped you?



Leave a reply

Author card Timothy Sykes picture

Timothy Sykes

Tim Sykes is a penny stock trader and teacher who became a self-made millionaire by the age of 22 by trading $12,415 of bar mitzvah money. After becoming disenchanted with the hedge fund world, he established the Tim Sykes Trading Challenge to teach aspiring traders how to follow his trading strategies. He’s been featured in a variety of media outlets including CNN, Larry King, Steve Harvey, Forbes, Men’s Journal, and more. He’s also an active philanthropist and environmental activist, a co-founder of Karmagawa, and has donated millions of dollars to charity.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”